MENU
RSMDF
AS OF
Oct 2 closing price
Price
$24.78
Change
-$2.33 (-8.59%)
Capitalization
36.63B
78 days until earnings call
Intraday BUY SELL Signals
+Compare
RSMDF
Stock ticker: OTC
AS OF
Oct 2 closing price
Price
$24.78
Change
-$2.33 (-8.59%)
Capitalization
36.63B

RSMDF stock forecast, quote, news & analysis

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more

RSMDF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RSMDF showed earnings on January 29, 2026. You can read more about the earnings report here.
Interact to see
Advertisement
A.I.Advisor
a Summary for RSMDF with price predictions
Feb 03, 2026

RSMDF in upward trend: price may jump up because it broke its lower Bollinger Band on January 07, 2026

RSMDF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 11 cases where RSMDF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 22, 2026. You may want to consider a long position or call options on RSMDF as a result. In of 38 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RSMDF just turned positive on January 22, 2026. Looking at past instances where RSMDF's MACD turned positive, the stock continued to rise in of 28 cases over the following month. The odds of a continued upward trend are .

RSMDF moved above its 50-day moving average on January 22, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RSMDF crossed bullishly above the 50-day moving average on January 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 148 cases where RSMDF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.452) is normal, around the industry mean (11.448). P/E Ratio (27.695) is within average values for comparable stocks, (149.436). Projected Growth (PEG Ratio) (1.853) is also within normal values, averaging (2.437). Dividend Yield (0.008) settles around the average of (0.017) among similar stocks. P/S Ratio (7.622) is also within normal values, averaging (111.001).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RSMDF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RSMDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

A.I.Advisor
published Dividends

RSMDF paid dividends on September 18, 2025

Resmed Inc. RSMDF Stock Dividends
А dividend of $0.06 per share was paid with a record date of September 18, 2025, and an ex-dividend date of August 13, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 11.34B. The market cap for tickers in the group ranges from 246 to 169.76B. ISRG holds the highest valuation in this group at 169.76B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 23%. CBSC experienced the highest price growth at 87%, while GCTK experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 18%. For the same stocks of the Industry, the average monthly volume growth was 35% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 66
Price Growth Rating: 62
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
RSMDF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
9001 Spectrum Center Boulevard
Phone
+1 858 836-5000
Employees
10140
Web
https://www.resmed.com